FDA Inspection 986640 — Vitalant

Vitalant — FEI 2076053

The FDA completed an inspection of Vitalant on September 15, 2016 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 15, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Phoenix, AZ (United States)